NEW DELHI: The Controller General of Medicines of India (DCGI) has directed the Serum Institute of India to suspend until new hires are ordered in the phase 2 and 3 clinical trials of the Oxford Covid-19 vaccine candidate in the context of the pharmaceutical giant AstraZeneca stopping trials in other …
Read More »DCGI Orders Serum Institute of India to Suspend Recruitment for Oxford Covid-19 Vaccine Trials | India News
